Novel approaches to support therapeutic development in ultra-rare cancers

Food and Drug Administration · Other Federal · FOR-FD-26-004

Source: Grants.gov · View original posting ↗

AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.

Amount not listed

DeadlineFinal application due date.

Not yet posted

Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).

—

MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).

—

DurationMaximum project period for a single award.

—

Expected awardsHow many awards the funder anticipates making under this opportunity.

—

Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).

Unknown

Open dateWhen applications open (or opened).

Aug 4, 2025

Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.

—

Clinical trialWhether proposed projects must, may, or must not include a clinical trial.

Unspecified